Diffuse stromal Leydig cell hyperplasia: A unique cause of postmenopausal hyperandrogenism and virilization

Mayo Clinic Proceedings

Volumn 75, Issue 3, 2000, Pages 288-292

  Taylor, Harris C ^a,b,c,d   Pillay, Indira ^a,b   Setrakian, Sebouh ^a,d  

^a FAIRVIEW HOSPITAL   (United States)

^b Department of Clinical and Molecular Endocrinology ^*  (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Lutheran Hospital Cleveland   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; LUTEINIZING HORMONE RECEPTOR; TESTOSTERONE;

ADULT; ALOPECIA; ARTICLE; CASE REPORT; CELL HYPERPLASIA; FEMALE; GENE SEQUENCE; HIRSUTISM; HUMAN; HUMAN TISSUE; HYPERANDROGENISM; LAPAROSCOPIC SURGERY; LEYDIG CELL; OVARIECTOMY; POSTMENOPAUSE; RECEPTOR GENE; STROMA CELL; TESTOSTERONE BLOOD LEVEL; VIRILIZATION;

EID: 0034008006     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.3.288     Document Type: Article

References (33)

1. Lobo RA. Ovarian hyperandrogenism and androgen-producing tumors. Endocrinol Metab Clin North Am. 1991 ;20:773-805.
2. Aiman J, Forney JP, Parker CR. Androgen and estrogen secretion by normal and neoplastic ovaries in premenopausal women. Obstet Gynecol. 1986;68:327-332.
3. Young RH, Scully RE. Sex cord-stromal and steroid cell ovarian tumors. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 4th ed. New York, NY: Springer-Verlag; 1994:783847.
4. Friedman CI, Schmidt GE, Kim MH, Powell J. Serum testosterone concentrations in the evaluation of androgen-producing tumors. Am J Obstet Gynecol. 1985;153:44-49.
5. Surrey ES, de Ziegler D, Gambone JC, Judd HL. Preoperative localization of androgen-secreting tumors: clinical, endocrinologie, and radiologie evaluation of ten patients. Am J Obstet Gynecol. 1988;158:1313-1322.
6. McLellan AR, Mowat A, Cordiner J, et al. Hilus cell pathology and hirsutism. Clin Endocrinol (Oxf). 1990;32:203-212.
7. de Santiago M, Herranz L, Ordas J, Atienza M, Suarez-Mier M, Gancedo PG. Leuprolide suppression of androgen secretion by hilus cell hyperplasia within the wall of an ovarian cyst. Clin Endocrinol (Oxf). 1996;45:239-242.
8. Sternberg WH. The morphology, androgenic function, hyperplasia and tumors of the ovarian hilus cell. Am J Pathol. 1949;25:493521.
9. Parish JM, Lufkin EG, Lee RA, Gaffey TA. Ovarian leiomyoma with hilus cell hyperplasia that caused virilization. Mayo Clin Proc. 1984;59:275-277.
10. Hayes FJ, Sheahan K, Rajendiran S, McKenna TJ. Virilization in a postmenopausal woman as a result of hilus cell hyperplasia associated with a simple ovarian cyst. Am J Obstet Gynecol. 1997; 176: 719-720.
11. Taliaferro I, Wells E, Kay S, Hoge RH. Ovarian hilus cell (Leydig cell) hyperplasia associated with masculinization. Arch Intern Med. 1953;91:675-684.
12. Siganos EC. Two cases of virilization associated with ovarian hilar cell activity. J Obstet Gynecol. 1961;68:979-981.
13. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961 ;21:1440-1447.
14. Misrahi M, Meduri G, Pissard S, et al. Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor. J Clin Endocrinol Metab. 1997;82:2159-2165.
15. Carr BR. Disorders of the ovaries and female reproductive tract. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams Textbook of Endocrinology. 9th ed. Philadelphia, Pa: WB Saunders Co; 1998:751-817.
16. Chang RJ, Katz SE. Diagnosis of polycystic ovary syndrome. Endocrinol Metab Clin North Am. 1999;28:397-408.
17. Dennefors BL, Janson PO, Hamberger L, Knutsson F. Hilus cells from human postmenopausal ovaries: gonadotrophin sensitivity, steroid and cyclic AMP production. Acta Obstet Gynecol Scand. 1982;61:413-416.
18. Hayes MC, Scully RE. Ovarian steroid cell tumors (not otherwise specified): a clinicopathological analysis of 63 cases. Am J Surg Pathol. 1987;11:835-845.
19. Taylor HB, Morris HJ. Lipid cell tumors of the ovary. Cancer. 1967;20:1953-1962.
20. Stewart RS, Woodward DE. Malignant ovarian hilus cell tumor. Arch Pathol. 1962;73:91-96.
21. Bertram KA, Bratloff B, Hodges GF, Davidson H. Treatment of malignant Leydig cell tumor. Cancer. 1991;68:2324-2329.
22. Echt CR, Hadd HE. Androgen excretion patterns in a patient with a metastatic hilus cell tumor of the ovary. Am J Obstet Gynecol. 1968;100:1055-1061.
23. Kennedy L, Traub AI, Atkinson AB, Sheridan B. Short term administration of gonadotropin-releasing hormone analog to a patient with a testosterone-secreting ovarian tumor. J Clin Endocrinol Metab. 1987;64:1320-1322.
24. Werk EE Jr, Sholiton LE, Kalejs L. Testosterone-secreting adrenal adenoma under gonadotropin control. N Engl J Med. 1973;289: 767-770.
25. Tucci JR, Zah W, Kalderon AE. Endocrine studies in an arrhenoblastoma responsive to dexamethasone, ACTH and human chorionic gonadotropin. Am J Med. 1973;55:687-694.
26. Suva PD, Sorensen ML, Reynertson R, Virata RL, Mahairas GH. Laparoscopic removal of virilizing hilar cell tumor in a postmenopausal patient. JAmAssoc Gynecol Laparosc. 1997;4:499-502.
27. Yano K, Saji M, Hidaka A, et al. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty. J Clin Endocrinol Metab. 1995;80:1162-1168.
28. Shenker A, Laue L, Kosugi S, Merendino JJ Jr, Minegishi T, Cutler GB Jr. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature. 1993; 365:652-654.
29. Latronico AC, Anasti J, Arnhold IJ, et al. A novel mutation of the luteinizing hormone receptor gene causing male gonadotropinindependent precocious puberty. J Clin Endocrinol Metab. 1995; 80:2490-2494.
30. Laue L, Chan WY, Hsueh AJ, et al. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc NatlAcadSci USA. 1995;92:1906-1910.
31. Lyons J, Landis CA, Harsh G, et al. Two G protein oncogenes in human endocrine tumors. Science. 1990;249:655-659.
32. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997; 18:774-800.
33. Matias-Guiu X, Prat J. Ovarian tumors with functioning stroma: an immunohistochemical study of 100 cases with human chorionic gonadotropin monoclonal and polyclonal antibodies. Cancer. 1990;65:2001-2005.